Market Research Report
Europe 3D Cell Culture Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||910167|
|Published||Content info||115 Pages
Delivery time: 2-3 business days
|Europe 3D Cell Culture Market Forecast 2019-2027|
|Published: September 6, 2019||Content info: 115 Pages||
The Europe 3D cell culture market is expected to project a CAGR of 11.66% during the forecast period. The rising awareness due to the conferences, workshops, and training programs is driving the growth of the market in the region.
The Europe 3D cell culture market is evaluated on the basis of the markets across the regions such as Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. The partnerships and alliances between the players in the market have been instrumental in contributing to the market share. Reinnervate Ltd. collaborated with pre-clinical Oncology CRO Oncotest GmbH and developed 3D cell culture technology, which was responsible for driving the growth of the market. Spain 3D cell culture market faces challenges with regards to low investments and funding, resulting in an estimated low growth during the forecast period. Italy is one of the leading countries in terms of regenerative medicine. The country has recorded rapid growth with regards to prototyping computer-controlled techniques. The countries in the Europe region are undergoing developments in healthcare along with conferences in 3D cell culture, thereby resulting in the enhancement of the scope of 3D cell culture markets across the countries of the region.
Some of the major companies in the market are Thermo Fisher Scientific Inc., Nano3D Biosciences, Inc., Promocell GmbH, Merck KGaA, Tecan Trading AG, VWR International LLC, etc.